Gedeon Richter Investment In Formycon Opens Up Collaboration Opportunities
Firm Takes 9% Stake In German Biosimilars Developer, Which Receives Over €80m
Gedeon Richter has agreed to acquire a stake of just over 9% in Formycon. The deal “opens up the possibility of jointly leveraging long-term strategic opportunities” while providing Formycon with more than €80m to invest in its biosimilar development projects.
